Acutaas Chemicals Limited (ACUTAAS)
BSE
Closed
Aug 25, 2026
Day's Range
3,136.1052 wk Range
1,290.05Overview - ACUTAAS - Acutaas Chemicals Limited
Key Statistics
Valuation
Enterprise Value
258.59B
P/E (Trailing)
‪92.09‬
P/E (Forward)
‪44.60‬
PEG Ratio
‪1.53‬
Price / Sales (TTM)
‪17.97‬
Price / Book
‪15.89‬
EV / EBITDA
‪47.58‬
Profitability
Gross Margin
‪57.91%‬
Profit Margin
‪26.42%‬
Operating Margin
‪31.31%‬
Return on Assets
‪10.24%‬
Return on Equity
‪12.02%‬
Ownership
Shares Outstanding
81.87M
Float
48.22M
Held by Insiders
‪38.31%‬
Held by Institutions
‪29.36%‬
Price stats
Beta
‪0.02‬
50-Day Avg
‪3,344.59‬
200-Day Avg
‪2,471.00‬
Dividends
Payout Ratio
‪4.29%‬
Frequency
Annual
Analyst Consensus
10 analysts
Average price target
‪₹ 2,973.40‬Market Cap - ACUTAAS - Acutaas Chemicals Limited
Peers - ACUTAAS - Acutaas Chemicals Limited
Peer Comparison
Compared with companies in Specialty Chemicals listed on BSE.
Profile Summary - ACUTAAS - Acutaas Chemicals Limited
About
Acutaas Chemicals Limited is an Indian specialty chemicals company specializing in the research, development, and manufacturing of advanced pharmaceutical intermediates. These intermediates serve as crucial components for regulated and generic active pharmaceutical ingredients (APIs) used in treatments such as…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
